Sapporo Clinical Laboratory Center, Inc. (9776) Stock Statistics & Valuation Metrics

Sapporo Clinical Laboratory Center, Inc. has a market cap or net worth of ¥3.46B. The enterprise value is ¥2.99B.

Sapporo Clinical Laboratory Center, Inc. has 4,216,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Sapporo Clinical Laboratory Center, Inc.’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 3.40%.

The current PE Ratio of Sapporo Clinical Laboratory Center, Inc. is 6.61. Sapporo Clinical Laboratory Center, Inc.’s PEG ratio is -0.17.

In the last 12 months, Sapporo Clinical Laboratory Center, Inc. had revenue of 20.13B and earned 464.18M in profits. Earnings per share was 148.35.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

Sapporo Clinical Laboratory Center, Inc. pays an annual dividend of ¥23, resulting in a dividend yield of 2.26%

Sapporo Clinical Laboratory Center, Inc. upcoming earnings date is Aug 11, 2025, TBA (Confirmed).

Sapporo Clinical Laboratory Center, Inc. as a current ratio of 2.13, with Debt / Equity ratio of 22.95%

In the past 12 months, Sapporo Clinical Laboratory Center, Inc. has paid 241.77M in taxes.

Sapporo Clinical Laboratory Center, Inc. EV to EBITDA ratio is 1.63, with an EV/FCF ratio of -4.19.

Sapporo Clinical Laboratory Center, Inc. has ¥3.63B in cash and marketable securities with ¥2.00B in debt, giving a net cash position of -¥1.63B billion.

Gross margin is 31.29%, with operating margin of 3.51%, and net profit margin of 2.31%.

The average price target for Sapporo Clinical Laboratory Center, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―